| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001202098 |
| P356 | DOI | 10.1038/SJ.BJC.6604228 |
| P932 | PMC publication ID | 2259175 |
| P698 | PubMed publication ID | 18253122 |
| P5875 | ResearchGate publication ID | 5599392 |
| P50 | author | Anne-Lise Børresen-Dale | Q11958220 |
| Patrick Concannon | Q30501095 | ||
| Lene Mellemkjaer | Q30501120 | ||
| Leslie Bernstein | Q60607806 | ||
| Kathleen E. Malone | Q110376035 | ||
| WECARE Study Collaborative Group | Q117253025 | ||
| P2093 | author name string | C F Lynch | |
| M Andersson | |||
| R W Haile | |||
| J Christensen | |||
| P Guldberg | |||
| J D Boice | |||
| D C Thomas | |||
| J H Olsen | |||
| M Stovall | |||
| B Langholz | |||
| C Dahl | |||
| J L Bernstein | |||
| M Capanu | |||
| L Bertelsen | |||
| P2860 | cites work | Variation of breast cancer risk among BRCA1/2 carriers | Q24646346 |
| Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study | Q24794680 | ||
| Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women | Q24795977 | ||
| Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations | Q28215462 | ||
| The CHEK2 gene and inherited breast cancer susceptibility | Q28265315 | ||
| CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies | Q33910280 | ||
| Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant | Q35443960 | ||
| Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study | Q35794366 | ||
| A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer | Q37218535 | ||
| Characterization of tumor-associated Chk2 mutations | Q42495187 | ||
| The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry | Q44897750 | ||
| Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients | Q45097069 | ||
| CHEK2 1100delC mutation is frequent among Russian breast cancer patients. | Q46169132 | ||
| Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers | Q48002614 | ||
| Chromosomal radiosensitivity of breast cancer with a CHEK2 mutation. | Q49097423 | ||
| The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population | Q59539024 | ||
| Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer | Q60200036 | ||
| Breast Cancer Survival and Tumor Characteristics in Premenopausal Women Carrying theCHEK2*1100delCGermline Mutation | Q61970254 | ||
| The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families | Q62978228 | ||
| Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland | Q79866004 | ||
| Increased risk of breast cancer associated with CHEK2*1100delC | Q80035778 | ||
| Pathology of breast cancer in women with constitutional CHEK2 mutations | Q81601356 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 728-733 | |
| P577 | publication date | 2008-02-05 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study | |
| P478 | volume | 98 |
| Q41873773 | A Bayesian Hierarchical Model for Relating Multiple SNPs within Multiple Genes to Disease Risk |
| Q39382156 | ATM, radiation, and the risk of second primary breast cancer |
| Q38776757 | Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study |
| Q38184906 | Bilateral breast cancers |
| Q57420847 | Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q34560743 | CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer |
| Q35889614 | CHEK2 contribution to hereditary breast cancer in non-BRCA families |
| Q37397658 | CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer |
| Q92630618 | Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation |
| Q55437668 | Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer. |
| Q33588213 | Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers |
| Q37421810 | Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). |
| Q39657506 | Hereditary breast cancer: the era of new susceptibility genes |
| Q30432746 | Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study |
| Q89970963 | Radiation treatment, ATM, BRCA1/2, and CHEK2*1100delC pathogenic variants, and risk of contralateral breast cancer |
| Q64055629 | Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms |
| Q34113473 | Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy |
| Q30423128 | Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study |
Search more.